A former employee of Tempus AI, Inc. has sued the Illinois-based company in federal court, alleging that her complaints to human resources about a hostile work environment triggered a months-long ...

Cathie Wood’s ARK Invest ETFs increased exposure to AI infrastructure, genomic medicine, fintech, and defense tech during the ...

Tempus AI TEM is leaning into a dual-engine model: a fast-growing Genomics franchise and a scaling data business powered by an expanding AI toolkit. The third quarter of 2025 marked a turn to non-GAAP ...

Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” first-quarter 2026 ...

AI-powered data company Tempus AI announced it will acquire Paige, an AI-enabled diagnostic platform for oncologists and pathologists, for $81.25 million. Tempus said the acquisition will help the ...

Artificial intelligence (AI) has been a huge investing theme over the past couple of years. Chances are, if you invested in a company involved with AI, you've seen its shares take off at some point.

Tempus AI TEM is slowly becoming one of the most vertically integrated data and diagnostics platforms in healthcare, bringing together genomics, multimodal real-world data and clinical AI into a ...

Great news for Tempus AI stock! The company has just received FDA approval for an upgraded version of its Tempus Pixel platform — a cardiac imaging system that uses advanced AI to deliver highly ...